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Mammalian brain contains a rich vas-
cular network. This network’s functional
activity, i.e., blood flow, is tightly con-
trolled by neural networks, although the
mechanisms of this control are not yet
clear. Understanding the link between
neuronal activity and cerebral blood flow
(CBF) is essential for both theoretical and
applied aspects of brain vascular dysfunc-
tions in neurodegenerative diseases (de la
Torre, 2012). Optogenetic techniques pro-
vide unique opportunities for monitoring
and modulating functions of specific neu-
rons and neuronal networks. An excellent
example is the recent study of Urban et al.
(2012) on regulation of CBF in the mouse
brain.
Up till now, three main hypothe-
sis have been put forward to explain
neuro-vascular coupling: metabolic, hemo-
neuronal, and neurogenic. The metabolic
hypothesis originates from the seminal
study of Roy and Sherrington propos-
ing that the regional CBF is regulated by
local metabolites (Roy and Sherrington,
1890). Since that time, a number of studies
suggested a causal link between neuronal
energy demands and regulation of the
local CBF (Hamel, 2006). The metabolic
hypothesis suggests that neurovascular
coupling is mediated by chemical signals
released from activated perivascular nerve
endings and astrocytes. These signals alter
vascular tone in order to locally adjust
blood supply according to the demands
of neuronal activity. This insures the CBF
coupling with regional glucose utilization,
which in turn is directly related to neuro-
glial activity (Magistretti, 2006).
The hemo-neuronal hypothesis pro-
poses that hemodynamics play a role in
information processing via modulation of
neural activity by blood flow. It suggests
that functional hyperemia, the “overflow”
of blood to a brain region during neural
activity, provides a spatially and tempo-
rally correlated source of regulation, mod-
ulating the excitability of the local circuit
(Moore and Cao, 2008).
The neurogenic hypothesis suggests that
neuronal synaptic signaling (rather than
metabolic needs) initiates a feed-forward
link to cerebrovascular reactions (Estrada
and Defelipe, 1998). This hypothesis is
supported by the observation that in the
brain slices from frontopariental cortex,
activation of a single interneuron is suf-
ficient to induce the vasomotor response
in local microvessel network (Cauli et al.,
2004). This suggests the ability of spe-
cific subsets of cortical GABA interneurons
to translate neuronal signals into vascu-
lar responses. Moreover, it has been pro-
posed that local activation of neurons and
astrocytes leads to a change in tone of
smooth muscles in surrounding arterioles
thus precisely modulating the blood flow
in a particular capillary bed (Kleinfeld
et al., 2011).
To test the last hypothesis, Urban
et al. (2012) used the optogenetic tools
for activating specific local neuronal net-
works and monitoring whether this causes
changes in a diameter of blood vessels
in the mouse brain slices. Their strat-
egy was based on the following main
approaches. First, they used a mutant of
ChR2-EYFP that has faster kinetics, which
allowed them to study the effects of opto-
genetic stimulation over a broad range of
frequencies (up to 200Hz). Second, they
used a Cre-dependant virus containing
ChETA-EYFP expression cassette under
the control of strong EF1α promoter that
ensured a high level of expression. Finally,
to restrict expression of ChR2-EYFP to
specific cells the authors used transgenic
mouse expressing Cre recombinase in neu-
rons containing parvalbumin (PV).
For monitoring the light-induced cur-
rents, the authors performed whole-cell
patch-clamp recordings and ascertained
that the fast spiking-PV interneurons reli-
ably fired action potentials in response to
the patterned blue light stimulation. Brain
slice preparation allowed the direct visu-
alization of microvessel movements and
contractions. For analysis of vascular reac-
tivity, the blood vessels of a>50μm length
and 8–30μm luminal diameter were
selected. Using infrared video microscopy,
the authors demonstrated that the opto-
genetic stimulation of PV-positive neurons
lead to a decrease in the diameter of arteri-
oles, indicating that photo-stimulation of
PV- containing neurons efficiently induces
a contraction of penetrating arterioles.
One important finding was that a sub-
class of PV-expressing pyramidal neurons
might also be a part of the neuronal system
that controls local blood flow by inducing
vasoconstriction. The authors conclude
that signaling from either fast spiking-
PV interneurons or PV-positive pyramids
could be involved in vasoconstriction of
penetrating arterioles.
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The more we know about neurovas-
cular coupling, the more we understand
that this extremely complex mechanism
cannot be explained within the frames of
any unidirectional hypothesis. Most likely,
this process reflects the combination of
feedback (metabolic) and feed-forward
(signaling) pathways. Moreover, both
pathway-mediated mechanisms closely
interact in regulation of blood flow. From
the perspective of neuronal function, the
hemodynamic signals may reflect both
neuronal inhibition and excitation, thus,
for a given brain area, the polarity of blood
oxygen level-dependent (BOLD) fMRI
signals may critically depend on the type
of synaptic input and therefore on the
balance between vasodilator and vasocon-
strictor molecules released by excitatory
and inhibitory neurons and astrocytes.
Up to now, there is no straightforward
interpretation of a positive or negative
BOLD signal in terms of the underlying
neuronal activity and hence on the type
of neurons that are activated. Taking into
account the complexity of the problem,
it is difficult to overestimate the impor-
tance of optogenetic approach since this
technique provides direct information on
the link between activity of certain sub-
class of neurons and correlated response
of the vascular system. Combination of
functional Magnetic Resonance Imaging
(fMRI) with optogenetics has been
successfully used for mapping neu-
ronal connectivity in the hippocampal
formation (Abe et al., 2012) and in other
domains (Desai et al., 2011). In the future,
optogenetics in combination with elec-
trophysiological (e.g., EEG, MEG) and
imaging tehniques (e.g., fMRI) promises
to provide a means to track changes in
the intact brain activity elicited by defined
neuronal populations and determine the
contributions of different cell types in the
network to the BOLD signal.
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